Cargando…

Pioglitazone for the Treatment of Metabolic-Associated Fatty Liver Disease in People Living With HIV and Prediabetes

Background Metabolic-associated fatty liver disease (MAFLD) is increasingly common among people living with the human immunodeficiency virus (PLHIV) and can progress to cirrhosis and cirrhotic-related complications. Pioglitazone is known to improve insulin sensitivity that results in decreasing seru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamolvisit, Sarunporn, Chirnaksorn, Supphamat, Nimitphong, Hataikarn, Sungkanuparph, Somnuek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2021
Materias:	Internal Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613454/ https://www.ncbi.nlm.nih.gov/pubmed/34858740 http://dx.doi.org/10.7759/cureus.19046

Ejemplares similares

Association between gut microbiota and prediabetes in people living with HIV
por: Jayanama, Kulapong, et al.
Publicado: (2022)

Metformin for Preventing Progression From Prediabetes to Diabetes Mellitus in People Living With Human Immunodeficiency Virus
por: Nimitphong, Hataikarn, et al.
Publicado: (2022)

2250. Metformin for Preventing Diabetes Mellitus in HIV-Infected Patients with Prediabetes: A Randomized Controlled Trial
por: Jiriyasin, Sitta, et al.
Publicado: (2018)

Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors
por: Phuphuakrat, Angsana, et al.
Publicado: (2020)

Effects of an intensive lifestyle intervention and the role of sleep in people living with HIV and prediabetes: a pilot and feasibility study
por: Nimitphong, Hataikarn, et al.
Publicado: (2021)

Vitamin E and Pioglitazone: A Comprehensive Systematic Review of Their Efficacy in Non-alcoholic Fatty Liver Disease
por: Mazhar, Iqra J, et al.
Publicado: (2023)

Urinary metabolic profiles after vitamin D(2) versus vitamin D(3) supplementation in prediabetes
por: Chailurkit, Laor, et al.
Publicado: (2019)

Efficacy of SGLT2 Inhibitors Versus Pioglitazone in the Treatment of Non-alcoholic Fatty Liver Disease or Non-alcoholic Steatohepatitis: A Systematic Review
por: Kaur, Simran, et al.
Publicado: (2023)

Vitamin D supplementation is associated with serum uric acid concentration in patients with prediabetes and hyperuricemia
por: Nimitphong, Hataikarn, et al.
Publicado: (2021)

EFFICACY AND SAFETY OF LOW DOSE COLCHICINE ON SURROGATE MARKERS OF CARDIOVASCULAR EVENTS IN PEOPLE LIVING WITH HIV RECEIVING ANTIRETROVIRAL THERAPY
por: Korkerdsup, Theerawat, et al.
Publicado: (2022)

Factors associated with patency of self-expandable metal stents in malignant biliary obstruction
por: Suksai, Nottawan, et al.
Publicado: (2023)

Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes
por: Klangjareonchai, Theerawut, et al.
Publicado: (2014)

Risk Factors of Renal Tubular Dysfunction in Thai People Living with HIV Receiving Tenofovir Disoproxil Fumarate
por: Phuphuakrat, Angsana, et al.
Publicado: (2022)

Thin Patient, Fatty Liver
por: Mukthinuthalapati, V V Pavan Kedar, et al.
Publicado: (2019)

The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review
por: Vemulapalli, Abhijith C, et al.
Publicado: (2023)

Integrated therapy for HIV and cryptococcosis
por: Srichatrapimuk, Sirawat, et al.
Publicado: (2016)

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study
por: Srichatrapimuk, Sirawat, et al.
Publicado: (2023)

Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease
por: Shrestha, Rupesh, et al.
Publicado: (2021)

Switching protease inhibitors to rilpivirine in HIV‐positive individuals with complete viral suppression and without prior HIV drug resistance in a resource‐limited setting: a randomized controlled trial
por: Palanuphap, Kulissara, et al.
Publicado: (2020)

Integrated therapy for HIV and tuberculosis
por: Manosuthi, Weerawat, et al.
Publicado: (2016)

Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD)
por: Parameswaran, Madhangi, et al.
Publicado: (2021)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Gallstones: A Systematic Review
por: Slouha, Ethan, et al.
Publicado: (2023)

Anthropometric Measurements and Lifestyle Characteristics of Individuals with Non-alcoholic Fatty Liver Disease
por: Tahir, Faryal, et al.
Publicado: (2020)

Switching Tenofovir/Emtricitabine/Efavirenz (TDF/FTC/EFV) to TDF/FTC/Rilpivirine vs Continuing TDF/FTC/EFV in HIV-Infected Patients With Virological Suppression: A Randomized Controlled Trial
por: Wiriyatanakorn, Sirichai, et al.
Publicado: (2019)

Can Nutritional Supplements Benefit Patients With Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease?
por: Baradeiya, Ahmed M, et al.
Publicado: (2023)

More evening preference is positively associated with systemic inflammation in prediabetes and type 2 diabetes patients
por: Nimitphong, Hataikarn, et al.
Publicado: (2018)

Impact of Fasting Lipid Profile on Chronic Kidney Disease Patients Having Fatty Liver Disease
por: Asghar, Muhammad Sohaib, et al.
Publicado: (2020)

The Significance of the Mediterranean Diet in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Gosal, Harpreet, et al.
Publicado: (2021)

A Multidisciplinary Approach and Current Perspective of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Zaman, Chowdhury F, et al.
Publicado: (2022)

Vitamin D status and sun exposure in southeast Asia
por: Nimitphong, Hataikarn, et al.
Publicado: (2013)

Vitamin D and Visceral Obesity in Humans: What Should Clinicians Know?
por: Chattranukulchai Shantavasinkul, Prapimporn, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Fibrosis Risk in Patients With Obstructive Sleep Apnea: A Retrospective Analysis
por: Jawa, Hani A, et al.
Publicado: (2021)

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs
por: TAKASHIMA, Satoshi, et al.
Publicado: (2021)

Non-alcoholic Fatty Liver Disease and Carbohydrate Restricted Diets: A Case Report and Literature Review
por: Gunaseelan, Luxhman, et al.
Publicado: (2021)

A Systematic Review of the Risk of Non-alcoholic Fatty Liver Disease in Women With Polycystic Ovary Syndrome
por: Shahbaz, Mahrukh, et al.
Publicado: (2022)

Accuracy of Ultrasonography vs. Elastography in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review
por: Geethakumari, Prabhitha, et al.
Publicado: (2022)

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Saudi Arabia: Systematic Review and Meta-analysis
por: Alenezi, Yusef M, et al.
Publicado: (2023)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Association of Metabolic-Associated Fatty Liver Disease With Various Anthropometric Parameters in Pre-diabetes in Comparison With Diabetes and Control: A Single Tertiary Care Center Study
por: Kolluru, Karthik, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3mvdb7to39rn396hm14bvoqaih